PL1996160T3 - Bioresorbowalna kompozycja o kontrolowanym uwalnianiu - Google Patents

Bioresorbowalna kompozycja o kontrolowanym uwalnianiu

Info

Publication number: PL1996160T3
Authority: PL; Poland
Prior art keywords: controlled; ceramic; bioresorbable; pharmaceutical composition; preparation
Prior art date: 2006-03-14

Application number

PL07711943T

Other languages

English (en)

Inventor

Niklas Axén

Hans Lennernäs

Original Assignee

Lidds Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-03-14

Filing date

2007-03-14

Publication date

2010-09-30

2007-03-14 Application filed by Lidds Ab filed Critical Lidds Ab

2010-09-30 Publication of PL1996160T3 publication Critical patent/PL1996160T3/pl

Links

238000013270 controlled release Methods 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
239000000919 ceramic Substances 0.000 abstract 3
239000013543 active substance Substances 0.000 abstract 2
OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 2
239000002246 antineoplastic agent Substances 0.000 abstract 1
235000011132 calcium sulphate Nutrition 0.000 abstract 1
239000001175 calcium sulphate Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000000887 hydrating effect Effects 0.000 abstract 1
230000002035 prolonged effect Effects 0.000 abstract 1
238000001228 spectrum Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Urology & Nephrology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Inorganic Chemistry (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL07711943T 2006-03-14 2007-03-14 Bioresorbowalna kompozycja o kontrolowanym uwalnianiu PL1996160T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DKPA200600361		2006-03-14
EP07711943A EP1996160B8 (en)	2006-03-14	2007-03-14	Bioresorbable controlled-release composition
PCT/EP2007/002250 WO2007104549A2 (en)	2006-03-14	2007-03-14	Bioresorbable controlled-release composition

Publications (1)

Publication Number	Publication Date
PL1996160T3 true PL1996160T3 (pl)	2010-09-30

Family

ID=36602790

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL07711943T PL1996160T3 (pl)	2006-03-14	2007-03-14	Bioresorbowalna kompozycja o kontrolowanym uwalnianiu

Country Status (18)

Country	Link
US (1)	US8999389B2 (pl)
EP (1)	EP1996160B8 (pl)
JP (1)	JP5216601B2 (pl)
KR (1)	KR101378174B1 (pl)
CN (1)	CN101431984B (pl)
AT (1)	ATE460154T1 (pl)
AU (1)	AU2007224651B8 (pl)
CA (1)	CA2644429C (pl)
DE (1)	DE602007005231D1 (pl)
DK (1)	DK1996160T3 (pl)
ES (1)	ES2342123T3 (pl)
HK (1)	HK1129061A1 (pl)
IL (1)	IL193973A (pl)
MX (1)	MX2008011606A (pl)
PL (1)	PL1996160T3 (pl)
RU (1)	RU2405537C2 (pl)
WO (1)	WO2007104549A2 (pl)
ZA (1)	ZA200807881B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL181834A (en)	2006-04-02	2011-04-28	Iscar Ltd	Cutting head and adaptor
ES2545962T3 (es) *	2008-11-27	2015-09-17	Lidds Ab	Uso de carboximetilcelulosa para controlar la capacidad de eyección y el tiempo de solidificación de composiciones que comprenden una o más cerámicas biorreabsorbibles
US20110313052A1 (en) *	2009-02-12	2011-12-22	Aduro Material Ab	Composition Comprising Biodegradable Carrier for Controlled Delivery
DK3086784T3 (da) *	2013-12-23	2019-06-17	Bcn Peptides Sa	Bicalutamid analoger eller (s)-bicalutamid som exocytose aktiverende forbindelser til brug i behandling af lysosomal lagringssygdom eller glycogenose
RU2750163C2 (ru)	2015-06-04	2021-06-22	Крититек, Инк.	Таксановые частицы и их применение
AU2017246316B2 (en)	2016-04-04	2022-09-29	Crititech, Inc.	Methods for solid tumor treatment
US10351437B2 (en)	2016-10-17	2019-07-16	Lidds Ab	Method for producing calcium sulphate hemihydrate with unique properties
CN110730679A (zh)	2017-06-09	2020-01-24	克里蒂泰克公司	囊内注射抗肿瘤颗粒治疗上皮囊肿
SG10201913400QA (en)	2017-06-14	2020-03-30	Crititech Inc	Methods for treating lung disorders
CA3076919A1 (en)	2017-10-03	2019-04-11	Crititech, Inc.	Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer
RU2683255C1 (ru) *	2018-03-06	2019-03-27	Федеральное государственное бюджетное учреждение науки Институт химии твердого тела Уральского отделения Российской академии наук	Биоактивный композиционный материал для замещения костных дефектов и способ его получения
WO2019170912A1 (en)	2018-03-09	2019-09-12	Lidds Ab	Bioresorbable controlled-release compositions with sting modulating molecules

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3797758A (en) *	1972-06-16	1974-03-19	Giulini Gmbh Geb	Method of producing finely dispersed alpha calcium sulfate hemihydrate
JP2702953B2 (ja)	1988-01-30	1998-01-26	オリンパス光学工業株式会社	薬液含浸セラミックス
US5055307A (en)	1988-12-29	1991-10-08	Asahi Kagaku Kogyo Kabushiki Kaisha	Slow release drug delivery granules and process for production thereof
US5614206A (en) *	1995-03-07	1997-03-25	Wright Medical Technology, Inc.	Controlled dissolution pellet containing calcium sulfate
US6132463A (en)	1995-05-19	2000-10-17	Etex Corporation	Cell seeding of ceramic compositions
US8333996B2 (en)	1995-05-19	2012-12-18	Etex Corporation	Calcium phosphate delivery vehicle and adjuvant
JP4260891B2 (ja) *	1996-10-16	2009-04-30	エテックスコーポレイション	生体セラミック組成物
US6391336B1 (en) *	1997-09-22	2002-05-21	Royer Biomedical, Inc.	Inorganic-polymer complexes for the controlled release of compounds including medicinals
SE9704400D0 (sv) *	1997-11-28	1997-11-28	Astra Ab	Porous inorganic particles as carriers for drug substances
US6030635A (en) *	1998-02-27	2000-02-29	Musculoskeletal Transplant Foundation	Malleable paste for filling bone defects
GB0020610D0 (en)	2000-08-21	2000-10-11	Dytech Corp Ltd	Uses of porous carriers
US6730324B2 (en) *	2001-04-20	2004-05-04	The University Of British Columbia	Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
SE522749C2 (sv) *	2002-03-04	2004-03-02	Cerbio Tech Ab	Ytbeläggningsförfarande, ytbelagd anordning och biokompatibel ytbeläggning
PL1680089T3 (pl) *	2003-10-22	2014-03-31	Lidds Ab	Kompozycja zawierająca biodegradowalną ceramikę hydratującą do kontrolowanego dostarczania leków

2007
- 2007-03-14 PL PL07711943T patent/PL1996160T3/pl unknown
- 2007-03-14 AU AU2007224651A patent/AU2007224651B8/en not_active Ceased
- 2007-03-14 EP EP07711943A patent/EP1996160B8/en active Active
- 2007-03-14 DE DE602007005231T patent/DE602007005231D1/de active Active
- 2007-03-14 KR KR1020087024798A patent/KR101378174B1/ko not_active Expired - Fee Related
- 2007-03-14 WO PCT/EP2007/002250 patent/WO2007104549A2/en active Application Filing
- 2007-03-14 MX MX2008011606A patent/MX2008011606A/es active IP Right Grant
- 2007-03-14 DK DK07711943.6T patent/DK1996160T3/da active
- 2007-03-14 JP JP2008558713A patent/JP5216601B2/ja active Active
- 2007-03-14 RU RU2008140519/15A patent/RU2405537C2/ru active
- 2007-03-14 US US12/224,942 patent/US8999389B2/en active Active
- 2007-03-14 ES ES07711943T patent/ES2342123T3/es active Active
- 2007-03-14 AT AT07711943T patent/ATE460154T1/de not_active IP Right Cessation
- 2007-03-14 CN CN2007800154671A patent/CN101431984B/zh not_active Expired - Fee Related
- 2007-03-14 CA CA2644429A patent/CA2644429C/en active Active
2008
- 2008-09-08 IL IL193973A patent/IL193973A/en active IP Right Grant
- 2008-09-12 ZA ZA200807881A patent/ZA200807881B/xx unknown
2009
- 2009-06-02 HK HK09104957.4A patent/HK1129061A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
KR101378174B1 (ko)	2014-03-27
RU2008140519A (ru)	2010-04-20
CN101431984A (zh)	2009-05-13
WO2007104549A3 (en)	2007-11-08
DE602007005231D1 (de)	2010-04-22
KR20080108128A (ko)	2008-12-11
AU2007224651B8 (en)	2011-10-27
RU2405537C2 (ru)	2010-12-10
JP5216601B2 (ja)	2013-06-19
EP1996160A2 (en)	2008-12-03
CA2644429C (en)	2014-07-29
US20090118215A1 (en)	2009-05-07
EP1996160B1 (en)	2010-03-10
EP1996160B8 (en)	2010-05-12
DK1996160T3 (da)	2010-07-05
ES2342123T3 (es)	2010-07-01
AU2007224651A8 (en)	2011-10-27
AU2007224651A1 (en)	2007-09-20
ATE460154T1 (de)	2010-03-15
ZA200807881B (en)	2009-10-28
IL193973A (en)	2012-07-31
MX2008011606A (es)	2008-09-22
CA2644429A1 (en)	2007-09-20
AU2007224651B2 (en)	2011-10-13
US8999389B2 (en)	2015-04-07
WO2007104549A2 (en)	2007-09-20
IL193973A0 (en)	2009-09-22
CN101431984B (zh)	2013-07-10
WO2007104549A8 (en)	2007-12-13
HK1129061A1 (en)	2009-11-20
JP2009529554A (ja)	2009-08-20

Publication	Publication Date	Title
EP1996160B8 (en)	2010-05-12	Bioresorbable controlled-release composition
WO2006044504A8 (en)	2006-06-08	Cgrp receptor antagonists
WO2006099268A3 (en)	2007-11-22	Cgrp receptor antagonists
WO2006029153A3 (en)	2006-05-26	Monocyclic anilide spirolactam cgrp receptor antagonists
WO2003028641A3 (en)	2003-08-28	Mch receptor antagonists
MY156822A (en)	2016-03-31	Indole derivatives as s1p1 receptor agonists
DK2321321T3 (da)	2012-05-21	Triazolo [4,5-d]pyramidinderivater og anvendelse deraf som purinreceptorantagonister
BRPI0715893A2 (pt)	2013-09-17	composto de azetidina e uso para a preparaÇço de um medicamento para a prevenÇço ou tratamento de distérbios distÍmicos ou do sono
UA96308C2 (ru)	2011-10-25	Антагонисты рецептора глюкагона, композиция, которая содержит такие соединения, и их применение
NO20081593L (no)	2008-03-31	Depotsammensetning
NO20070487L (no)	2007-03-05	3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer.
MX2009004746A (es)	2009-05-22	Derivados de 1,2,4-triazol como inhibidores del receptor sigma.
WO2006031491A3 (en)	2006-11-09	Tricyclic anilide spirolactam cgrp receptor antagonists
WO2008112159A3 (en)	2008-10-30	Monocyclic anilide spirolactam cgrp receptor antagonists
WO2006004741A3 (en)	2006-05-04	3-aminocyclopentanecarboxamides as modulators of chemokine receptors
SI2018169T1 (sl)	2011-02-28	Uporaba 4,17 beta-dihidroksiandrost-4-en-3-ona za zdravljenje raka
WO2008048801A3 (en)	2008-06-05	Phenylalkylamino carbamate compositions
NZ623674A (en)	2014-07-25	Vip fragments and methods of use
WO2007072201A3 (en)	2007-10-04	3-aminocyclopentanecarboxamides as modulators of chemokine receptors
WO2006047196A3 (en)	2006-10-05	Cgrp receptor antagonists
WO2005115392A3 (en)	2006-02-02	3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors
WO2006031676A3 (en)	2007-04-26	Tricyclic anilide spirohydantoin cgrp receptor antagonists
MX2009003929A (es)	2009-06-26	Composiciones de fenilalquil carbamato.
WO2006041830A3 (en)	2006-06-01	Cgrp receptor antagonists
WO2007044251A3 (en)	2007-10-04	Pharmaceutical compositions